0001209191-17-003704.txt : 20170113 0001209191-17-003704.hdr.sgml : 20170113 20170113170238 ACCESSION NUMBER: 0001209191-17-003704 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170112 FILED AS OF DATE: 20170113 DATE AS OF CHANGE: 20170113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MATEON THERAPEUTICS INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. STREET 2: SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. STREET 2: SUITE 210 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: OXIGENE INC DATE OF NAME CHANGE: 19930628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schwieterman William D CENTRAL INDEX KEY: 0001403961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 17528513 MAIL ADDRESS: STREET 1: C/O OXIGENE, INC., 230 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-12 0 0000908259 MATEON THERAPEUTICS INC MATN 0001403961 Schwieterman William D C/O MATEON THERAPEUTICS, INC. 701 GATEWAY BLVD., SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President and CEO Employee Stock Option (Right to Buy) 0.375 2017-01-12 4 A 0 550000 0.375 A 2027-01-12 Common Stock 550000 550000 D Dr. Schwieterman was awarded options to purchase Mateon Therapeutics, Inc. common stock, $0.01 par value per share, pursuant to the Mateon Therapeutics, Inc. 2017 Equity Incentive Plan in connection with his service as President and Chief Executive Officer. The Options will vest in forty-eight equal monthly installments beginning one month after the grant date. /s/ Megan Gates, attorney-in-fact 2017-01-13